159 related articles for article (PubMed ID: 18391980)
1. Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
Perotti D; Gamba B; Sardella M; Spreafico F; Terenziani M; Collini P; Pession A; Nantron M; Fossati-Bellani F; Radice P
Oncogene; 2008 Jul; 27(33):4625-32. PubMed ID: 18391980
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
[TBL] [Abstract][Full Text] [Related]
3. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.
Rivera MN; Kim WJ; Wells J; Driscoll DR; Brannigan BW; Han M; Kim JC; Feinberg AP; Gerald WL; Vargas SO; Chin L; Iafrate AJ; Bell DW; Haber DA
Science; 2007 Feb; 315(5812):642-5. PubMed ID: 17204608
[TBL] [Abstract][Full Text] [Related]
4. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
[TBL] [Abstract][Full Text] [Related]
5. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
Ruteshouser EC; Robinson SM; Huff V
Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
[TBL] [Abstract][Full Text] [Related]
6. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits Wilms' tumor cell progression through upregulation of Wilms' tumor gene on the X chromosome.
Liu Y; Liu S
Mol Med Rep; 2013 Nov; 8(5):1537-41. PubMed ID: 24002362
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor genetics: a new, UnX-pected twist to the story.
Huff V
Cancer Cell; 2007 Feb; 11(2):105-7. PubMed ID: 17292822
[TBL] [Abstract][Full Text] [Related]
9. Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas.
Yoo NJ; Kim S; Lee SH
Dig Dis Sci; 2009 May; 54(5):1011-4. PubMed ID: 18720004
[TBL] [Abstract][Full Text] [Related]
10. Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein.
Camp ND; James RG; Dawson DW; Yan F; Davison JM; Houck SA; Tang X; Zheng N; Major MB; Moon RT
J Biol Chem; 2012 Feb; 287(9):6539-50. PubMed ID: 22215675
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
Akhavanfard S; Vargas SO; Han M; Nitta M; Chang CB; Le LP; Fazlollahi L; Nguyen Q; Ma Y; Cosper A; Dias-Santagata D; Han JY; Bergethon K; Borger DR; Ellisen LW; Pomeroy SL; Haber DA; Iafrate AJ; Rivera MN
Genes Chromosomes Cancer; 2014 Jan; 53(1):67-77. PubMed ID: 24249259
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants.
Kim MK; Min DJ; Rabin M; Licht JD
Oncogene; 2011 Feb; 30(7):832-42. PubMed ID: 20956941
[TBL] [Abstract][Full Text] [Related]
13. The General Expression Analysis of WTX Gene in Normal and Cancer Tissues.
Zhang YY; Wang QM; Niu HL; Liu X; Zhang QL
Pathol Oncol Res; 2017 Apr; 23(2):439-446. PubMed ID: 28032309
[TBL] [Abstract][Full Text] [Related]
14. WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.
Fukuzawa R; Holman SK; Chow CW; Savarirayan R; Reeve AE; Robertson SP
J Med Genet; 2010 Nov; 47(11):791-4. PubMed ID: 20679664
[TBL] [Abstract][Full Text] [Related]
15. Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.
Alexandrescu S; Akhavanfard S; Harris MH; Vargas SO
Pediatr Dev Pathol; 2017; 20(2):105-111. PubMed ID: 28326956
[TBL] [Abstract][Full Text] [Related]
16. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
[TBL] [Abstract][Full Text] [Related]
17. Canonical WNT signalling determines lineage specificity in Wilms tumour.
Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.
Drake KM; Ruteshouser EC; Natrajan R; Harbor P; Wegert J; Gessler M; Pritchard-Jones K; Grundy P; Dome J; Huff V; Jones C; Aldred MA
Clin Cancer Res; 2009 Oct; 15(19):5985-92. PubMed ID: 19789318
[TBL] [Abstract][Full Text] [Related]
19. Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene?
Guertl B; Leuschner I; Guelly C; Ebner B; Kronberger C; Hoefler G
Pathol Oncol Res; 2010 Jun; 16(2):189-91. PubMed ID: 19757195
[TBL] [Abstract][Full Text] [Related]
20. Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases.
Safford SD; Goyeau D; Freemerman AJ; Bentley R; Everett ML; Grundy PE; Skinner MA
Ann Surg Oncol; 2003 Mar; 10(2):136-43. PubMed ID: 12620908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]